Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Injuries | 110 | 2024 | 2025 | 9.190 |
Why?
|
Brain Concussion | 75 | 2024 | 1320 | 8.580 |
Why?
|
Football | 35 | 2023 | 460 | 6.380 |
Why?
|
Recovery of Function | 51 | 2022 | 2925 | 5.050 |
Why?
|
Spinal Cord Injuries | 36 | 2024 | 931 | 4.590 |
Why?
|
Athletic Injuries | 35 | 2023 | 1154 | 3.920 |
Why?
|
Rehabilitation Centers | 26 | 2022 | 254 | 2.880 |
Why?
|
Inpatients | 24 | 2022 | 2518 | 2.330 |
Why?
|
Post-Concussion Syndrome | 11 | 2024 | 219 | 2.220 |
Why?
|
Glasgow Coma Scale | 27 | 2021 | 570 | 1.940 |
Why?
|
Athletes | 34 | 2023 | 1093 | 1.930 |
Why?
|
Sports | 7 | 2023 | 688 | 1.750 |
Why?
|
Burns | 19 | 2022 | 1815 | 1.610 |
Why?
|
Disability Evaluation | 26 | 2022 | 1827 | 1.570 |
Why?
|
Cytidine Diphosphate Choline | 6 | 2019 | 30 | 1.500 |
Why?
|
Muscle Spasticity | 7 | 2010 | 154 | 1.480 |
Why?
|
Soccer | 7 | 2023 | 133 | 1.470 |
Why?
|
Suicidal Ideation | 6 | 2022 | 1248 | 1.430 |
Why?
|
Amantadine | 6 | 2020 | 55 | 1.380 |
Why?
|
Sports Medicine | 3 | 2021 | 225 | 1.320 |
Why?
|
Dopamine Agents | 6 | 2018 | 189 | 1.290 |
Why?
|
Cognition | 31 | 2024 | 6770 | 1.240 |
Why?
|
Stress Disorders, Post-Traumatic | 15 | 2023 | 4266 | 1.240 |
Why?
|
Trauma Severity Indices | 8 | 2021 | 481 | 1.210 |
Why?
|
Epilepsy, Post-Traumatic | 5 | 2021 | 40 | 1.170 |
Why?
|
Suicide | 4 | 2023 | 1477 | 1.160 |
Why?
|
Rehabilitation | 7 | 2023 | 134 | 1.150 |
Why?
|
Cognition Disorders | 14 | 2020 | 4043 | 1.140 |
Why?
|
Physicians, Women | 5 | 2019 | 486 | 1.130 |
Why?
|
Humans | 365 | 2024 | 744343 | 1.110 |
Why?
|
Activities of Daily Living | 24 | 2021 | 2418 | 1.070 |
Why?
|
Spinal Cord Neoplasms | 3 | 2018 | 281 | 1.060 |
Why?
|
Placebo Effect | 3 | 2021 | 502 | 1.040 |
Why?
|
Brain Injury, Chronic | 6 | 2018 | 68 | 1.030 |
Why?
|
Nootropic Agents | 5 | 2019 | 160 | 0.990 |
Why?
|
Physical Therapy Modalities | 11 | 2021 | 550 | 0.980 |
Why?
|
Osteopathic Medicine | 2 | 2021 | 14 | 0.980 |
Why?
|
Consciousness | 7 | 2022 | 572 | 0.960 |
Why?
|
Male | 242 | 2024 | 350118 | 0.930 |
Why?
|
Neuropsychological Tests | 36 | 2023 | 6993 | 0.890 |
Why?
|
Mental Disorders | 10 | 2023 | 6600 | 0.880 |
Why?
|
Adult | 166 | 2024 | 214055 | 0.850 |
Why?
|
Exercise Therapy | 6 | 2023 | 906 | 0.840 |
Why?
|
Persistent Vegetative State | 5 | 2021 | 260 | 0.820 |
Why?
|
Xenon | 1 | 2022 | 110 | 0.810 |
Why?
|
Quality of Life | 23 | 2023 | 12804 | 0.800 |
Why?
|
Awards and Prizes | 4 | 2019 | 375 | 0.800 |
Why?
|
Patient Readmission | 14 | 2022 | 3114 | 0.800 |
Why?
|
Amnesia | 4 | 2019 | 248 | 0.780 |
Why?
|
Craniocerebral Trauma | 8 | 2021 | 482 | 0.760 |
Why?
|
Middle Aged | 149 | 2024 | 213383 | 0.760 |
Why?
|
Female | 198 | 2024 | 380194 | 0.750 |
Why?
|
Neuronal Plasticity | 6 | 2021 | 1422 | 0.740 |
Why?
|
Neurology | 3 | 2019 | 763 | 0.710 |
Why?
|
Health Status Indicators | 6 | 2020 | 969 | 0.710 |
Why?
|
Length of Stay | 23 | 2022 | 6309 | 0.700 |
Why?
|
Vital Signs | 1 | 2021 | 142 | 0.700 |
Why?
|
Apomorphine | 2 | 2010 | 150 | 0.700 |
Why?
|
Memantine | 1 | 2020 | 100 | 0.680 |
Why?
|
Industry | 1 | 2021 | 365 | 0.680 |
Why?
|
Hemiplegia | 2 | 2016 | 135 | 0.680 |
Why?
|
Dopamine Agonists | 4 | 2010 | 355 | 0.660 |
Why?
|
Neuroprotective Agents | 7 | 2016 | 941 | 0.660 |
Why?
|
Military Personnel | 5 | 2023 | 1133 | 0.650 |
Why?
|
United States | 67 | 2023 | 69872 | 0.640 |
Why?
|
Peer Review, Research | 1 | 2021 | 329 | 0.620 |
Why?
|
Periodicals as Topic | 2 | 2019 | 1432 | 0.620 |
Why?
|
Consciousness Disorders | 8 | 2023 | 418 | 0.610 |
Why?
|
Biomedical Research | 6 | 2021 | 3309 | 0.600 |
Why?
|
Employment | 7 | 2021 | 1132 | 0.600 |
Why?
|
Cross-Sectional Studies | 41 | 2024 | 25043 | 0.590 |
Why?
|
Chordoma | 2 | 2017 | 359 | 0.590 |
Why?
|
Neurosurgical Procedures | 3 | 2018 | 2002 | 0.580 |
Why?
|
Veterans | 5 | 2022 | 2519 | 0.570 |
Why?
|
Frail Elderly | 2 | 2019 | 693 | 0.570 |
Why?
|
Anal Canal | 1 | 2019 | 376 | 0.560 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 12 | 2022 | 3658 | 0.560 |
Why?
|
Botulinum Toxins, Type A | 3 | 2010 | 213 | 0.560 |
Why?
|
Self Report | 13 | 2023 | 3558 | 0.550 |
Why?
|
Glasgow Outcome Scale | 4 | 2021 | 109 | 0.550 |
Why?
|
Brain | 27 | 2023 | 26385 | 0.550 |
Why?
|
Sleep Apnea Syndromes | 2 | 2023 | 944 | 0.540 |
Why?
|
Depression | 15 | 2022 | 7766 | 0.540 |
Why?
|
Software Design | 1 | 2016 | 176 | 0.540 |
Why?
|
Neuromuscular Agents | 2 | 2010 | 134 | 0.540 |
Why?
|
Chronic Disease | 10 | 2023 | 9146 | 0.530 |
Why?
|
Adolescent | 69 | 2023 | 85781 | 0.520 |
Why?
|
Central Nervous System Agents | 1 | 2016 | 72 | 0.520 |
Why?
|
Authorship | 1 | 2018 | 271 | 0.520 |
Why?
|
Prospective Studies | 38 | 2024 | 53288 | 0.510 |
Why?
|
Neurodegenerative Diseases | 2 | 2023 | 1061 | 0.510 |
Why?
|
Injury Severity Score | 12 | 2021 | 1014 | 0.500 |
Why?
|
Aged | 85 | 2022 | 163280 | 0.490 |
Why?
|
Sciatica | 1 | 2015 | 98 | 0.490 |
Why?
|
Astrocytoma | 2 | 2018 | 790 | 0.490 |
Why?
|
Evidence-Based Medicine | 3 | 2019 | 3610 | 0.490 |
Why?
|
Disabled Persons | 4 | 2022 | 1212 | 0.480 |
Why?
|
Regenerative Medicine | 1 | 2018 | 307 | 0.480 |
Why?
|
Electric Stimulation Therapy | 3 | 2021 | 605 | 0.480 |
Why?
|
Information Systems | 1 | 2016 | 410 | 0.470 |
Why?
|
Young Adult | 42 | 2024 | 56430 | 0.470 |
Why?
|
Health Surveys | 5 | 2019 | 4037 | 0.470 |
Why?
|
Inservice Training | 1 | 2016 | 392 | 0.460 |
Why?
|
Central Nervous System | 2 | 2011 | 1357 | 0.460 |
Why?
|
Cyclohexanecarboxylic Acids | 2 | 2004 | 141 | 0.450 |
Why?
|
Neuralgia | 5 | 2018 | 570 | 0.450 |
Why?
|
Pediatrics | 2 | 2019 | 3475 | 0.450 |
Why?
|
Treatment Outcome | 39 | 2023 | 63114 | 0.450 |
Why?
|
Wounds, Gunshot | 4 | 2014 | 563 | 0.440 |
Why?
|
Irritable Mood | 3 | 2021 | 183 | 0.430 |
Why?
|
Retrospective Studies | 50 | 2024 | 77449 | 0.430 |
Why?
|
Amines | 2 | 2004 | 276 | 0.430 |
Why?
|
Occupational Health | 1 | 2019 | 809 | 0.430 |
Why?
|
Anesthesia | 1 | 2024 | 1561 | 0.430 |
Why?
|
Patient Discharge | 11 | 2022 | 3313 | 0.420 |
Why?
|
Mental Health | 6 | 2023 | 3019 | 0.420 |
Why?
|
Stem Cell Transplantation | 2 | 2018 | 1620 | 0.420 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2938 | 0.420 |
Why?
|
Academies and Institutes | 2 | 2019 | 317 | 0.410 |
Why?
|
Aftercare | 1 | 2018 | 866 | 0.410 |
Why?
|
Nerve Net | 2 | 2021 | 2174 | 0.400 |
Why?
|
Sciatic Nerve | 1 | 2015 | 607 | 0.400 |
Why?
|
Comorbidity | 12 | 2021 | 10388 | 0.400 |
Why?
|
Environment | 7 | 2020 | 1124 | 0.390 |
Why?
|
Head Injuries, Penetrating | 2 | 2001 | 28 | 0.390 |
Why?
|
Severity of Illness Index | 10 | 2021 | 15540 | 0.390 |
Why?
|
Neoplastic Stem Cells | 2 | 2018 | 1376 | 0.390 |
Why?
|
Healthcare Disparities | 3 | 2024 | 3158 | 0.390 |
Why?
|
Wheelchairs | 4 | 2018 | 77 | 0.380 |
Why?
|
Nervous System Diseases | 2 | 2020 | 1622 | 0.380 |
Why?
|
Publishing | 1 | 2018 | 833 | 0.380 |
Why?
|
Neurosurgery | 1 | 2017 | 643 | 0.380 |
Why?
|
Prognosis | 25 | 2023 | 29063 | 0.380 |
Why?
|
Neural Stem Cells | 1 | 2018 | 851 | 0.370 |
Why?
|
Aging | 4 | 2023 | 8664 | 0.370 |
Why?
|
Insurance, Health | 1 | 2023 | 2494 | 0.370 |
Why?
|
Respiration, Artificial | 2 | 2021 | 2569 | 0.370 |
Why?
|
Trauma Centers | 5 | 2021 | 890 | 0.370 |
Why?
|
Wound Infection | 1 | 2012 | 242 | 0.360 |
Why?
|
Psychomotor Agitation | 3 | 2008 | 293 | 0.360 |
Why?
|
Postural Balance | 5 | 2020 | 620 | 0.360 |
Why?
|
Exercise | 3 | 2018 | 5615 | 0.360 |
Why?
|
Spinal Diseases | 1 | 2015 | 538 | 0.360 |
Why?
|
Critical Care | 6 | 2020 | 2647 | 0.360 |
Why?
|
Methylphenidate | 4 | 2018 | 473 | 0.360 |
Why?
|
Longitudinal Studies | 16 | 2022 | 13989 | 0.360 |
Why?
|
Research Report | 1 | 2013 | 355 | 0.350 |
Why?
|
8-Hydroxy-2-(di-n-propylamino)tetralin | 5 | 2008 | 32 | 0.350 |
Why?
|
Cohort Studies | 21 | 2023 | 40561 | 0.350 |
Why?
|
Double-Blind Method | 14 | 2023 | 12026 | 0.340 |
Why?
|
Benchmarking | 2 | 2019 | 1042 | 0.330 |
Why?
|
Mesenchymal Stem Cell Transplantation | 3 | 2019 | 496 | 0.330 |
Why?
|
Maze Learning | 12 | 2010 | 478 | 0.330 |
Why?
|
Robotics | 1 | 2016 | 899 | 0.320 |
Why?
|
Anxiety | 8 | 2023 | 4297 | 0.320 |
Why?
|
Complementary Therapies | 3 | 2021 | 486 | 0.320 |
Why?
|
Databases, Factual | 13 | 2021 | 7729 | 0.320 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2021 | 3923 | 0.320 |
Why?
|
Suicide, Attempted | 1 | 2016 | 1221 | 0.310 |
Why?
|
gamma-Aminobutyric Acid | 2 | 2004 | 1121 | 0.310 |
Why?
|
Brain Diseases | 2 | 2012 | 1563 | 0.310 |
Why?
|
Aggression | 5 | 2021 | 753 | 0.310 |
Why?
|
Demography | 4 | 2022 | 1656 | 0.310 |
Why?
|
Aged, 80 and over | 27 | 2021 | 57776 | 0.310 |
Why?
|
Headache | 6 | 2023 | 1226 | 0.300 |
Why?
|
Time Factors | 32 | 2021 | 40075 | 0.300 |
Why?
|
Health Promotion | 1 | 2020 | 2205 | 0.300 |
Why?
|
Education, Medical, Graduate | 1 | 2019 | 2291 | 0.300 |
Why?
|
Practice Guidelines as Topic | 5 | 2021 | 7279 | 0.300 |
Why?
|
Risk Factors | 31 | 2023 | 72290 | 0.290 |
Why?
|
Health Status | 4 | 2020 | 4034 | 0.290 |
Why?
|
Public Health | 1 | 2020 | 2603 | 0.280 |
Why?
|
Walking | 5 | 2020 | 1180 | 0.280 |
Why?
|
Neurotransmitter Agents | 2 | 2009 | 647 | 0.280 |
Why?
|
Cardiovascular Diseases | 7 | 2023 | 15165 | 0.280 |
Why?
|
Pilot Projects | 9 | 2024 | 8324 | 0.280 |
Why?
|
Follow-Up Studies | 24 | 2021 | 39050 | 0.280 |
Why?
|
Stem Cells | 2 | 2018 | 3567 | 0.280 |
Why?
|
Patient Dropouts | 2 | 2019 | 421 | 0.280 |
Why?
|
Coma | 2 | 2021 | 475 | 0.270 |
Why?
|
Patient Care Team | 2 | 2021 | 2531 | 0.270 |
Why?
|
Stroke | 8 | 2023 | 9981 | 0.270 |
Why?
|
Sesquiterpenes | 2 | 2019 | 177 | 0.270 |
Why?
|
Drug Therapy | 1 | 2009 | 497 | 0.270 |
Why?
|
Institutionalization | 2 | 2017 | 104 | 0.260 |
Why?
|
Alkaloids | 2 | 2019 | 190 | 0.260 |
Why?
|
Diffusion Tensor Imaging | 6 | 2023 | 2305 | 0.260 |
Why?
|
Age Factors | 18 | 2020 | 18370 | 0.260 |
Why?
|
Health Personnel | 2 | 2016 | 3218 | 0.250 |
Why?
|
Serotonin Receptor Agonists | 4 | 2008 | 152 | 0.250 |
Why?
|
Transcranial Magnetic Stimulation | 4 | 2020 | 1432 | 0.250 |
Why?
|
Hippocampus | 8 | 2019 | 3675 | 0.250 |
Why?
|
Biotechnology | 1 | 2006 | 281 | 0.240 |
Why?
|
Predictive Value of Tests | 12 | 2023 | 15076 | 0.240 |
Why?
|
Hand Deformities, Acquired | 1 | 2004 | 36 | 0.240 |
Why?
|
Patient Transfer | 5 | 2020 | 761 | 0.240 |
Why?
|
Cerebrovascular Disorders | 1 | 2011 | 1504 | 0.240 |
Why?
|
Arousal | 2 | 2014 | 1165 | 0.240 |
Why?
|
Early Ambulation | 2 | 2016 | 44 | 0.240 |
Why?
|
Motor Activity | 13 | 2015 | 2714 | 0.240 |
Why?
|
Survivors | 6 | 2022 | 2291 | 0.240 |
Why?
|
Dementia | 4 | 2022 | 2518 | 0.230 |
Why?
|
Self-Help Devices | 2 | 2021 | 67 | 0.230 |
Why?
|
Memory Disorders | 2 | 2015 | 1184 | 0.230 |
Why?
|
Cell Proliferation | 2 | 2018 | 10481 | 0.220 |
Why?
|
Combined Modality Therapy | 6 | 2021 | 8642 | 0.220 |
Why?
|
Patient Admission | 2 | 2020 | 1380 | 0.220 |
Why?
|
Resilience, Psychological | 2 | 2022 | 676 | 0.220 |
Why?
|
Upper Extremity | 3 | 2021 | 648 | 0.220 |
Why?
|
Skull Fractures | 1 | 2004 | 195 | 0.210 |
Why?
|
Factor Analysis, Statistical | 5 | 2016 | 977 | 0.210 |
Why?
|
Brain Chemistry | 2 | 2017 | 981 | 0.210 |
Why?
|
Ginkgo biloba | 1 | 2001 | 26 | 0.210 |
Why?
|
Craniotomy | 4 | 2016 | 729 | 0.210 |
Why?
|
Epidural Abscess | 1 | 2003 | 84 | 0.210 |
Why?
|
tau Proteins | 4 | 2023 | 1868 | 0.200 |
Why?
|
Hypertension | 1 | 2022 | 8480 | 0.200 |
Why?
|
Delphi Technique | 2 | 2023 | 778 | 0.200 |
Why?
|
Herbal Medicine | 1 | 2001 | 37 | 0.200 |
Why?
|
Cell Differentiation | 2 | 2018 | 11483 | 0.200 |
Why?
|
Gases | 1 | 2022 | 197 | 0.200 |
Why?
|
Schools | 8 | 2023 | 1433 | 0.200 |
Why?
|
Headache Disorders | 1 | 2023 | 130 | 0.200 |
Why?
|
Central Nervous System Stimulants | 3 | 2018 | 1148 | 0.200 |
Why?
|
Depressive Disorder, Major | 1 | 2019 | 4644 | 0.190 |
Why?
|
Plant Preparations | 1 | 2001 | 94 | 0.190 |
Why?
|
Sex Ratio | 2 | 2018 | 110 | 0.190 |
Why?
|
Neural Prostheses | 1 | 2021 | 21 | 0.190 |
Why?
|
Incidence | 13 | 2021 | 20947 | 0.190 |
Why?
|
Hockey | 1 | 2021 | 90 | 0.190 |
Why?
|
Burns, Inhalation | 1 | 2020 | 33 | 0.190 |
Why?
|
Sex Factors | 13 | 2020 | 10397 | 0.190 |
Why?
|
Risk Assessment | 10 | 2021 | 23338 | 0.190 |
Why?
|
Psychomotor Performance | 6 | 2014 | 1901 | 0.190 |
Why?
|
Motor Cortex | 2 | 2018 | 986 | 0.180 |
Why?
|
Paraplegia | 3 | 2018 | 168 | 0.180 |
Why?
|
Tomography, Emission-Computed | 2 | 2001 | 1144 | 0.180 |
Why?
|
Animals | 37 | 2022 | 168757 | 0.180 |
Why?
|
Carbamazepine | 1 | 2021 | 229 | 0.180 |
Why?
|
Cerebral Hemorrhage, Traumatic | 1 | 2019 | 20 | 0.180 |
Why?
|
Sodium Channel Blockers | 1 | 2021 | 176 | 0.180 |
Why?
|
Sleep Initiation and Maintenance Disorders | 4 | 2015 | 1004 | 0.180 |
Why?
|
Rats, Sprague-Dawley | 19 | 2019 | 8301 | 0.180 |
Why?
|
Mind-Body Therapies | 2 | 2013 | 247 | 0.180 |
Why?
|
Facial Paralysis | 1 | 2004 | 338 | 0.180 |
Why?
|
Behavior Therapy | 1 | 2005 | 865 | 0.180 |
Why?
|
Hospitalization | 9 | 2023 | 10262 | 0.170 |
Why?
|
Phytotherapy | 1 | 2001 | 298 | 0.170 |
Why?
|
Intracranial Hemorrhages | 2 | 2021 | 855 | 0.170 |
Why?
|
Education | 2 | 2021 | 543 | 0.170 |
Why?
|
Temporal Bone | 1 | 2004 | 661 | 0.170 |
Why?
|
Attitude of Health Personnel | 3 | 2021 | 3843 | 0.170 |
Why?
|
Wounds, Penetrating | 2 | 2002 | 307 | 0.170 |
Why?
|
Logistic Models | 12 | 2021 | 13408 | 0.170 |
Why?
|
Brain-Derived Neurotrophic Factor | 2 | 2018 | 604 | 0.170 |
Why?
|
Community Health Services | 1 | 2004 | 650 | 0.170 |
Why?
|
Patient Selection | 3 | 2019 | 4215 | 0.170 |
Why?
|
After-Hours Care | 1 | 2020 | 102 | 0.170 |
Why?
|
Occupational Diseases | 2 | 2019 | 1471 | 0.170 |
Why?
|
Memory | 6 | 2018 | 2174 | 0.160 |
Why?
|
Carbon Monoxide | 1 | 2022 | 531 | 0.160 |
Why?
|
Pruritus | 2 | 2019 | 361 | 0.160 |
Why?
|
Age Distribution | 3 | 2019 | 2902 | 0.160 |
Why?
|
Bone Density | 6 | 2024 | 3468 | 0.160 |
Why?
|
Trauma, Nervous System | 1 | 2018 | 36 | 0.160 |
Why?
|
Off-Label Use | 1 | 2020 | 169 | 0.160 |
Why?
|
Gait | 2 | 2019 | 793 | 0.160 |
Why?
|
Bicycling | 1 | 2019 | 176 | 0.160 |
Why?
|
Frontal Lobe | 1 | 2005 | 1406 | 0.160 |
Why?
|
Needs Assessment | 3 | 2018 | 1147 | 0.160 |
Why?
|
Toes | 1 | 2019 | 206 | 0.160 |
Why?
|
Baseball | 1 | 2019 | 90 | 0.160 |
Why?
|
Pamphlets | 1 | 2018 | 75 | 0.160 |
Why?
|
Gait Disorders, Neurologic | 1 | 2020 | 231 | 0.160 |
Why?
|
Prevalence | 6 | 2021 | 15226 | 0.160 |
Why?
|
Cerebral Infarction | 2 | 2018 | 1011 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 15 | 2022 | 35421 | 0.160 |
Why?
|
Plant Extracts | 1 | 2001 | 471 | 0.160 |
Why?
|
Adiponectin | 2 | 2014 | 1100 | 0.160 |
Why?
|
Medicare | 5 | 2022 | 6566 | 0.160 |
Why?
|
Violence | 3 | 2002 | 909 | 0.160 |
Why?
|
Sex Distribution | 2 | 2021 | 2297 | 0.160 |
Why?
|
Medical Futility | 1 | 2019 | 127 | 0.150 |
Why?
|
Diagnostic Self Evaluation | 1 | 2019 | 230 | 0.150 |
Why?
|
Phenols | 1 | 2001 | 497 | 0.150 |
Why?
|
Osteoporosis | 4 | 2016 | 1580 | 0.150 |
Why?
|
Posture | 2 | 2001 | 958 | 0.150 |
Why?
|
Clinical Protocols | 2 | 2016 | 1462 | 0.150 |
Why?
|
Physical Examination | 4 | 2021 | 1237 | 0.150 |
Why?
|
Neurobiology | 1 | 2018 | 121 | 0.150 |
Why?
|
Motor Skills | 2 | 2018 | 522 | 0.150 |
Why?
|
Antipsychotic Agents | 5 | 2009 | 3057 | 0.150 |
Why?
|
Regression Analysis | 7 | 2021 | 6459 | 0.150 |
Why?
|
Coculture Techniques | 2 | 2018 | 1341 | 0.150 |
Why?
|
Hyponatremia | 2 | 1997 | 298 | 0.150 |
Why?
|
Sensation | 1 | 2019 | 336 | 0.150 |
Why?
|
Dopamine | 4 | 2007 | 1591 | 0.150 |
Why?
|
Advisory Committees | 1 | 2021 | 775 | 0.150 |
Why?
|
Cholinesterase Inhibitors | 1 | 2019 | 238 | 0.150 |
Why?
|
Adrenal Cortex Hormones | 1 | 2006 | 1855 | 0.150 |
Why?
|
Inappropriate ADH Syndrome | 1 | 1997 | 61 | 0.150 |
Why?
|
Psychopharmacology | 1 | 2019 | 143 | 0.150 |
Why?
|
Withholding Treatment | 1 | 2021 | 599 | 0.150 |
Why?
|
Bone Morphogenetic Proteins | 2 | 2012 | 838 | 0.140 |
Why?
|
Subacute Care | 1 | 2019 | 168 | 0.140 |
Why?
|
Behavior, Animal | 7 | 2013 | 1881 | 0.140 |
Why?
|
Exercise Tolerance | 2 | 2021 | 770 | 0.140 |
Why?
|
Journal Impact Factor | 1 | 2018 | 156 | 0.140 |
Why?
|
Cerebral Cortex | 6 | 2019 | 5708 | 0.140 |
Why?
|
Neuromuscular Blocking Agents | 1 | 2017 | 130 | 0.140 |
Why?
|
Anger | 1 | 2019 | 402 | 0.140 |
Why?
|
Foreign-Body Migration | 1 | 1998 | 222 | 0.140 |
Why?
|
Self Care | 2 | 2021 | 786 | 0.140 |
Why?
|
Osteoarthritis, Hip | 1 | 2021 | 412 | 0.140 |
Why?
|
Climate Change | 1 | 2022 | 418 | 0.140 |
Why?
|
Neuromuscular Blockade | 1 | 2017 | 146 | 0.140 |
Why?
|
Water-Electrolyte Imbalance | 1 | 1997 | 113 | 0.140 |
Why?
|
Embolism, Air | 1 | 1996 | 111 | 0.140 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2019 | 260 | 0.140 |
Why?
|
Patient Care Planning | 2 | 2016 | 921 | 0.140 |
Why?
|
Drinking | 1 | 1997 | 197 | 0.140 |
Why?
|
Publications | 1 | 2018 | 195 | 0.130 |
Why?
|
Rats | 20 | 2019 | 24260 | 0.130 |
Why?
|
Erectile Dysfunction | 1 | 2019 | 461 | 0.130 |
Why?
|
Drug Administration Schedule | 5 | 2017 | 4933 | 0.130 |
Why?
|
Analysis of Variance | 10 | 2017 | 6365 | 0.130 |
Why?
|
Gonadal Steroid Hormones | 3 | 2024 | 712 | 0.130 |
Why?
|
Galantamine | 1 | 2015 | 32 | 0.130 |
Why?
|
Levodopa | 1 | 2016 | 219 | 0.130 |
Why?
|
Sex Characteristics | 4 | 2015 | 2585 | 0.130 |
Why?
|
Consensus | 2 | 2023 | 2959 | 0.130 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2018 | 689 | 0.130 |
Why?
|
Tomography, X-Ray Computed | 10 | 2021 | 20129 | 0.130 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2018 | 2737 | 0.130 |
Why?
|
Wounds, Nonpenetrating | 2 | 2002 | 794 | 0.130 |
Why?
|
Nerve Block | 1 | 2001 | 644 | 0.130 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2018 | 475 | 0.130 |
Why?
|
Tissue Scaffolds | 2 | 2019 | 956 | 0.130 |
Why?
|
Ethanol | 1 | 2001 | 1342 | 0.130 |
Why?
|
Muscle, Skeletal | 1 | 2010 | 4931 | 0.130 |
Why?
|
Corpus Callosum | 1 | 2019 | 737 | 0.130 |
Why?
|
Carbolines | 1 | 2016 | 265 | 0.120 |
Why?
|
Models, Neurological | 2 | 2020 | 1774 | 0.120 |
Why?
|
Neurologic Examination | 5 | 2006 | 930 | 0.120 |
Why?
|
Liver Transplantation | 1 | 2005 | 2119 | 0.120 |
Why?
|
Home Care Services | 1 | 2001 | 606 | 0.120 |
Why?
|
Nerve Regeneration | 1 | 2000 | 788 | 0.120 |
Why?
|
Terminology as Topic | 2 | 2018 | 1547 | 0.120 |
Why?
|
Body Temperature | 2 | 2016 | 777 | 0.120 |
Why?
|
Disease Management | 2 | 2017 | 2459 | 0.120 |
Why?
|
Societies, Medical | 4 | 2020 | 3743 | 0.120 |
Why?
|
Pyramidal Tracts | 1 | 2016 | 256 | 0.120 |
Why?
|
Migraine Disorders | 3 | 2021 | 1620 | 0.120 |
Why?
|
Autistic Disorder | 1 | 2023 | 1185 | 0.120 |
Why?
|
Movement Disorders | 2 | 2010 | 445 | 0.120 |
Why?
|
Computer Security | 1 | 2016 | 262 | 0.120 |
Why?
|
Muscle Relaxants, Central | 2 | 2004 | 86 | 0.120 |
Why?
|
Reproducibility of Results | 8 | 2021 | 19905 | 0.120 |
Why?
|
Universities | 1 | 2019 | 956 | 0.120 |
Why?
|
Lipid Peroxidation | 3 | 2006 | 270 | 0.120 |
Why?
|
Intraoperative Care | 1 | 2017 | 767 | 0.120 |
Why?
|
Adrenergic alpha-Agonists | 2 | 2004 | 177 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1071 | 0.110 |
Why?
|
Recurrence | 4 | 2017 | 8340 | 0.110 |
Why?
|
Hypopituitarism | 1 | 2015 | 254 | 0.110 |
Why?
|
Disease Models, Animal | 12 | 2022 | 18029 | 0.110 |
Why?
|
Case-Control Studies | 8 | 2021 | 21746 | 0.110 |
Why?
|
Burn Units | 1 | 2013 | 136 | 0.110 |
Why?
|
Tumor Necrosis Factor Ligand Superfamily Member 13 | 1 | 2013 | 40 | 0.110 |
Why?
|
Unconsciousness | 2 | 2014 | 263 | 0.110 |
Why?
|
Subtraction Technique | 1 | 2016 | 525 | 0.110 |
Why?
|
Perceptual Disorders | 1 | 2015 | 196 | 0.110 |
Why?
|
Acetates | 2 | 2004 | 311 | 0.110 |
Why?
|
Bromocriptine | 2 | 2004 | 111 | 0.110 |
Why?
|
B-Cell Activating Factor | 1 | 2013 | 119 | 0.110 |
Why?
|
Muscle Weakness | 1 | 2016 | 413 | 0.110 |
Why?
|
Feasibility Studies | 5 | 2018 | 5078 | 0.110 |
Why?
|
Retirement | 3 | 2019 | 215 | 0.110 |
Why?
|
Intensive Care Units | 3 | 2016 | 3679 | 0.110 |
Why?
|
Mental Processes | 1 | 2014 | 249 | 0.110 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3133 | 0.110 |
Why?
|
Social Participation | 1 | 2014 | 173 | 0.110 |
Why?
|
Osteoporotic Fractures | 2 | 2014 | 401 | 0.110 |
Why?
|
Students | 3 | 2020 | 1654 | 0.110 |
Why?
|
Video Recording | 1 | 2017 | 949 | 0.110 |
Why?
|
Bone Resorption | 1 | 2016 | 723 | 0.110 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3240 | 0.110 |
Why?
|
History, 21st Century | 1 | 2018 | 1534 | 0.100 |
Why?
|
Syndrome | 4 | 2021 | 3251 | 0.100 |
Why?
|
Accidents, Traffic | 4 | 2019 | 819 | 0.100 |
Why?
|
B-Cell Maturation Antigen | 1 | 2013 | 140 | 0.100 |
Why?
|
Arthroplasty, Replacement, Hip | 2 | 2021 | 1462 | 0.100 |
Why?
|
Guidelines as Topic | 1 | 2019 | 1405 | 0.100 |
Why?
|
Disabled Children | 1 | 2014 | 247 | 0.100 |
Why?
|
Fractures, Bone | 1 | 2024 | 1947 | 0.100 |
Why?
|
Confidentiality | 1 | 2016 | 612 | 0.100 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2015 | 271 | 0.100 |
Why?
|
Catheterization, Central Venous | 1 | 1996 | 514 | 0.100 |
Why?
|
Rest | 1 | 2016 | 901 | 0.100 |
Why?
|
Child | 9 | 2022 | 77709 | 0.100 |
Why?
|
Mobility Limitation | 1 | 2015 | 409 | 0.100 |
Why?
|
Absorptiometry, Photon | 4 | 2024 | 1725 | 0.100 |
Why?
|
Skiing | 1 | 2011 | 24 | 0.100 |
Why?
|
Sleep | 3 | 2017 | 4623 | 0.100 |
Why?
|
Abdomen | 1 | 2017 | 1118 | 0.100 |
Why?
|
Independent Living | 3 | 2022 | 568 | 0.100 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2021 | 1414 | 0.100 |
Why?
|
Neovascularization, Physiologic | 1 | 2018 | 1351 | 0.100 |
Why?
|
Phototherapy | 1 | 2014 | 377 | 0.100 |
Why?
|
Pain | 5 | 2023 | 4986 | 0.090 |
Why?
|
Executive Function | 1 | 2019 | 1364 | 0.090 |
Why?
|
Registries | 3 | 2021 | 8089 | 0.090 |
Why?
|
Spinal Cord Compression | 1 | 2013 | 235 | 0.090 |
Why?
|
Antioxidants | 1 | 2019 | 1663 | 0.090 |
Why?
|
Statistics, Nonparametric | 5 | 2017 | 2886 | 0.090 |
Why?
|
Mesenchymal Stem Cells | 2 | 2018 | 1632 | 0.090 |
Why?
|
Seizures | 3 | 2022 | 2859 | 0.090 |
Why?
|
Osteoarthritis, Knee | 1 | 2021 | 1222 | 0.090 |
Why?
|
Sensitivity and Specificity | 7 | 2018 | 14722 | 0.090 |
Why?
|
Emergency Service, Hospital | 3 | 2019 | 7659 | 0.090 |
Why?
|
History, 20th Century | 1 | 2018 | 2740 | 0.090 |
Why?
|
Brain Ischemia | 2 | 2020 | 3265 | 0.090 |
Why?
|
Infusions, Subcutaneous | 1 | 2010 | 42 | 0.090 |
Why?
|
Diagnosis, Differential | 4 | 2019 | 12959 | 0.090 |
Why?
|
Interdisciplinary Communication | 1 | 2016 | 950 | 0.090 |
Why?
|
Spinal Neoplasms | 1 | 2017 | 760 | 0.090 |
Why?
|
Haloperidol | 2 | 2008 | 397 | 0.090 |
Why?
|
Quadriplegia | 3 | 2018 | 223 | 0.090 |
Why?
|
Amygdala | 1 | 2018 | 1315 | 0.090 |
Why?
|
Interprofessional Relations | 2 | 2019 | 1011 | 0.090 |
Why?
|
Neck Pain | 1 | 2011 | 180 | 0.090 |
Why?
|
Pain Measurement | 5 | 2018 | 3420 | 0.090 |
Why?
|
Ibuprofen | 1 | 2011 | 236 | 0.090 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2021 | 1458 | 0.090 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2017 | 6038 | 0.090 |
Why?
|
Subarachnoid Hemorrhage | 1 | 1997 | 1018 | 0.090 |
Why?
|
Molecular Imaging | 1 | 2016 | 828 | 0.090 |
Why?
|
Risperidone | 2 | 2008 | 383 | 0.090 |
Why?
|
Deep Brain Stimulation | 1 | 2017 | 748 | 0.090 |
Why?
|
Afghan Campaign 2001- | 1 | 2010 | 272 | 0.090 |
Why?
|
Maine | 2 | 2021 | 139 | 0.090 |
Why?
|
Internship and Residency | 2 | 2019 | 5788 | 0.090 |
Why?
|
Atropine | 1 | 2009 | 244 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2017 | 10943 | 0.080 |
Why?
|
Self Efficacy | 1 | 2013 | 616 | 0.080 |
Why?
|
Social Environment | 2 | 2014 | 1023 | 0.080 |
Why?
|
Electroencephalography | 3 | 2020 | 6150 | 0.080 |
Why?
|
Oxygen | 1 | 2021 | 4189 | 0.080 |
Why?
|
Reaction Time | 6 | 2017 | 2097 | 0.080 |
Why?
|
Research Design | 5 | 2019 | 5987 | 0.080 |
Why?
|
Testosterone | 1 | 2019 | 2420 | 0.080 |
Why?
|
Movement | 1 | 2016 | 1471 | 0.080 |
Why?
|
Diffuse Axonal Injury | 1 | 2009 | 49 | 0.080 |
Why?
|
Cooperative Behavior | 1 | 2016 | 1504 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1797 | 0.080 |
Why?
|
Delivery of Health Care | 4 | 2021 | 5319 | 0.080 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1831 | 0.080 |
Why?
|
Intention | 2 | 2021 | 341 | 0.080 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2018 | 2942 | 0.080 |
Why?
|
Blinking | 1 | 2009 | 138 | 0.080 |
Why?
|
Positron-Emission Tomography | 3 | 2023 | 6234 | 0.080 |
Why?
|
Weight Gain | 1 | 2018 | 2292 | 0.080 |
Why?
|
Dopamine Uptake Inhibitors | 2 | 2007 | 312 | 0.080 |
Why?
|
Lactic Acid | 3 | 2017 | 1133 | 0.080 |
Why?
|
Verbal Learning | 2 | 2001 | 467 | 0.080 |
Why?
|
Forearm | 1 | 2010 | 409 | 0.080 |
Why?
|
Estrous Cycle | 2 | 2007 | 73 | 0.080 |
Why?
|
Glutamic Acid | 3 | 2017 | 1169 | 0.080 |
Why?
|
3,4-Dihydroxyphenylacetic Acid | 1 | 2007 | 64 | 0.080 |
Why?
|
Accidental Falls | 2 | 2011 | 1062 | 0.080 |
Why?
|
Homovanillic Acid | 1 | 2007 | 75 | 0.080 |
Why?
|
Mortality | 1 | 2019 | 2864 | 0.080 |
Why?
|
Socioeconomic Factors | 8 | 2020 | 7785 | 0.070 |
Why?
|
Medical History Taking | 1 | 2011 | 783 | 0.070 |
Why?
|
Psychometrics | 4 | 2018 | 3002 | 0.070 |
Why?
|
Hospitals | 3 | 2021 | 3952 | 0.070 |
Why?
|
Injections | 1 | 2010 | 840 | 0.070 |
Why?
|
Anticonvulsants | 3 | 2007 | 1916 | 0.070 |
Why?
|
Hospitals, General | 1 | 2011 | 749 | 0.070 |
Why?
|
Hip Fractures | 1 | 2015 | 955 | 0.070 |
Why?
|
Nicotine | 2 | 2022 | 681 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 2016 | 2645 | 0.070 |
Why?
|
Firearms | 1 | 2014 | 598 | 0.070 |
Why?
|
Neurons | 4 | 2019 | 9338 | 0.070 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2018 | 1736 | 0.070 |
Why?
|
Lower Extremity | 1 | 2014 | 1158 | 0.070 |
Why?
|
International Classification of Diseases | 3 | 2016 | 867 | 0.070 |
Why?
|
Wounds and Injuries | 1 | 2018 | 2400 | 0.070 |
Why?
|
Parkinsonian Disorders | 1 | 2009 | 275 | 0.070 |
Why?
|
Basal Ganglia Cerebrovascular Disease | 1 | 2005 | 7 | 0.070 |
Why?
|
Hypnotics and Sedatives | 1 | 2014 | 1162 | 0.070 |
Why?
|
Diabetes Insipidus | 2 | 2015 | 151 | 0.070 |
Why?
|
Odds Ratio | 4 | 2021 | 9849 | 0.070 |
Why?
|
Encephalomalacia | 1 | 2005 | 17 | 0.070 |
Why?
|
Attention | 2 | 2015 | 2400 | 0.070 |
Why?
|
Health Care Costs | 2 | 2014 | 3209 | 0.070 |
Why?
|
Adaptation, Physiological | 1 | 2012 | 1312 | 0.070 |
Why?
|
Family | 1 | 2016 | 3147 | 0.070 |
Why?
|
Sepsis | 1 | 2019 | 2593 | 0.070 |
Why?
|
Blast Injuries | 1 | 2009 | 302 | 0.060 |
Why?
|
Cyproheptadine | 1 | 2004 | 21 | 0.060 |
Why?
|
Placebos | 1 | 2009 | 1676 | 0.060 |
Why?
|
Antidepressive Agents | 2 | 2009 | 2838 | 0.060 |
Why?
|
Qualitative Research | 2 | 2024 | 2682 | 0.060 |
Why?
|
Dantrolene | 1 | 2004 | 26 | 0.060 |
Why?
|
Ganglia, Spinal | 2 | 2018 | 519 | 0.060 |
Why?
|
Autoimmunity | 1 | 2013 | 1349 | 0.060 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2009 | 789 | 0.060 |
Why?
|
Exploratory Behavior | 2 | 2022 | 270 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2022 | 9959 | 0.060 |
Why?
|
Acute Disease | 3 | 2012 | 7149 | 0.060 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2007 | 422 | 0.060 |
Why?
|
Cell Line, Tumor | 2 | 2018 | 16689 | 0.060 |
Why?
|
Surgical Procedures, Operative | 1 | 2016 | 1876 | 0.060 |
Why?
|
Hypothermia, Induced | 3 | 2005 | 752 | 0.060 |
Why?
|
Algorithms | 4 | 2023 | 13881 | 0.060 |
Why?
|
4-Aminopyridine | 1 | 2004 | 81 | 0.060 |
Why?
|
Clinical Competence | 1 | 2000 | 4687 | 0.060 |
Why?
|
Management Information Systems | 1 | 2004 | 50 | 0.060 |
Why?
|
Serotonin Antagonists | 1 | 2004 | 144 | 0.060 |
Why?
|
Skilled Nursing Facilities | 2 | 2019 | 372 | 0.060 |
Why?
|
Piracetam | 1 | 2004 | 87 | 0.060 |
Why?
|
Neostriatum | 1 | 2005 | 250 | 0.060 |
Why?
|
Serotonin 5-HT1 Receptor Agonists | 1 | 2004 | 43 | 0.060 |
Why?
|
Baclofen | 1 | 2004 | 129 | 0.060 |
Why?
|
Pyruvic Acid | 1 | 2005 | 200 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2018 | 8949 | 0.060 |
Why?
|
Neurosciences | 1 | 2008 | 348 | 0.060 |
Why?
|
Splints | 1 | 2004 | 111 | 0.060 |
Why?
|
Up-Regulation | 1 | 2012 | 4217 | 0.060 |
Why?
|
Florida | 1 | 2004 | 435 | 0.060 |
Why?
|
Forecasting | 2 | 2016 | 2951 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 3327 | 0.060 |
Why?
|
Weight-Bearing | 2 | 2016 | 515 | 0.050 |
Why?
|
Casts, Surgical | 1 | 2004 | 178 | 0.050 |
Why?
|
Injections, Intramuscular | 1 | 2004 | 552 | 0.050 |
Why?
|
Confidence Intervals | 2 | 2020 | 2971 | 0.050 |
Why?
|
Fluvoxamine | 1 | 2002 | 74 | 0.050 |
Why?
|
Neural Conduction | 1 | 2004 | 440 | 0.050 |
Why?
|
Physicians | 1 | 2021 | 4567 | 0.050 |
Why?
|
Germany | 2 | 2016 | 862 | 0.050 |
Why?
|
Health Expenditures | 1 | 2015 | 2348 | 0.050 |
Why?
|
Critical Illness | 2 | 2016 | 2670 | 0.050 |
Why?
|
Case Management | 1 | 2004 | 286 | 0.050 |
Why?
|
Pyridines | 1 | 2014 | 2825 | 0.050 |
Why?
|
Multivariate Analysis | 5 | 2022 | 12245 | 0.050 |
Why?
|
Receptors, Serotonin | 1 | 2002 | 201 | 0.050 |
Why?
|
Prescriptions | 1 | 2004 | 387 | 0.050 |
Why?
|
Ethics Committees, Research | 1 | 2023 | 194 | 0.050 |
Why?
|
Survival Rate | 2 | 2015 | 12788 | 0.050 |
Why?
|
Paroxetine | 1 | 2002 | 182 | 0.050 |
Why?
|
Mass Screening | 1 | 2017 | 5255 | 0.050 |
Why?
|
Arm | 2 | 2021 | 589 | 0.050 |
Why?
|
Torticollis | 1 | 2001 | 66 | 0.050 |
Why?
|
Selegiline | 1 | 2001 | 31 | 0.050 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 3255 | 0.050 |
Why?
|
Anisotropy | 2 | 2016 | 1265 | 0.050 |
Why?
|
Catechols | 1 | 2001 | 61 | 0.050 |
Why?
|
Glycine | 1 | 2004 | 671 | 0.050 |
Why?
|
Sertraline | 1 | 2002 | 206 | 0.050 |
Why?
|
Receptors, Presynaptic | 1 | 2000 | 15 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 2282 | 0.050 |
Why?
|
Glioma | 1 | 2016 | 3401 | 0.050 |
Why?
|
Benzophenones | 1 | 2001 | 57 | 0.050 |
Why?
|
Discriminant Analysis | 1 | 2001 | 235 | 0.050 |
Why?
|
Adrenergic Agonists | 1 | 2021 | 58 | 0.050 |
Why?
|
Pleasure | 1 | 2021 | 41 | 0.050 |
Why?
|
Fingers | 1 | 2004 | 513 | 0.050 |
Why?
|
Radius | 1 | 2024 | 422 | 0.050 |
Why?
|
Antibodies, Neutralizing | 1 | 2010 | 1978 | 0.050 |
Why?
|
Nitrophenols | 1 | 2001 | 172 | 0.050 |
Why?
|
Smoke | 1 | 2022 | 227 | 0.050 |
Why?
|
Texas | 1 | 2001 | 392 | 0.040 |
Why?
|
Forensic Medicine | 1 | 2000 | 64 | 0.040 |
Why?
|
Benzothiazoles | 1 | 2001 | 248 | 0.040 |
Why?
|
Swimming | 2 | 2012 | 206 | 0.040 |
Why?
|
Models, Statistical | 1 | 2014 | 5102 | 0.040 |
Why?
|
Receptors, Dopamine | 1 | 2000 | 295 | 0.040 |
Why?
|
Social Adjustment | 2 | 1999 | 631 | 0.040 |
Why?
|
Vascular Headaches | 1 | 1999 | 22 | 0.040 |
Why?
|
Citalopram | 1 | 2002 | 403 | 0.040 |
Why?
|
Locomotion | 2 | 2017 | 378 | 0.040 |
Why?
|
Synaptic Transmission | 1 | 2005 | 1178 | 0.040 |
Why?
|
Middle Cerebral Artery | 1 | 2020 | 264 | 0.040 |
Why?
|
Academic Medical Centers | 1 | 2009 | 2759 | 0.040 |
Why?
|
Head Protective Devices | 1 | 2019 | 114 | 0.040 |
Why?
|
Remote Sensing Technology | 1 | 2019 | 90 | 0.040 |
Why?
|
Cluster Analysis | 2 | 2018 | 2715 | 0.040 |
Why?
|
Benzodiazepines | 1 | 2004 | 1101 | 0.040 |
Why?
|
Health Services Research | 2 | 2009 | 1836 | 0.040 |
Why?
|
Random Allocation | 3 | 2010 | 2429 | 0.040 |
Why?
|
Fluoxetine | 1 | 2002 | 749 | 0.040 |
Why?
|
Postoperative Complications | 2 | 2017 | 15295 | 0.040 |
Why?
|
Gender Identity | 1 | 2004 | 688 | 0.040 |
Why?
|
Single-Blind Method | 2 | 2016 | 1590 | 0.040 |
Why?
|
Heart Rate | 1 | 2009 | 4091 | 0.040 |
Why?
|
Caregivers | 2 | 2024 | 2094 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2012 | 5317 | 0.040 |
Why?
|
Gait Ataxia | 1 | 2017 | 12 | 0.040 |
Why?
|
Tibia | 1 | 2024 | 1077 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2020 | 629 | 0.040 |
Why?
|
Tissue Distribution | 2 | 2016 | 2327 | 0.040 |
Why?
|
Research Subjects | 1 | 2019 | 239 | 0.040 |
Why?
|
Venous Thromboembolism | 1 | 2010 | 1671 | 0.040 |
Why?
|
Brain Damage, Chronic | 1 | 1998 | 265 | 0.040 |
Why?
|
Time Perception | 1 | 1998 | 84 | 0.040 |
Why?
|
Range of Motion, Articular | 1 | 2004 | 1578 | 0.040 |
Why?
|
Nerve Growth Factors | 1 | 2000 | 574 | 0.040 |
Why?
|
Liver Diseases | 1 | 2005 | 1253 | 0.040 |
Why?
|
Ultrasonography | 1 | 2010 | 5985 | 0.040 |
Why?
|
Job Satisfaction | 1 | 2021 | 535 | 0.040 |
Why?
|
Terminally Ill | 1 | 2019 | 238 | 0.040 |
Why?
|
Marital Status | 1 | 2018 | 437 | 0.040 |
Why?
|
Peripheral Nerves | 1 | 2020 | 466 | 0.040 |
Why?
|
Oxidative Stress | 2 | 2004 | 3086 | 0.040 |
Why?
|
Sensation Disorders | 1 | 2017 | 155 | 0.040 |
Why?
|
Homeostasis | 2 | 1998 | 3340 | 0.030 |
Why?
|
Hematoma, Subdural | 1 | 1997 | 126 | 0.030 |
Why?
|
Systems Analysis | 1 | 2017 | 172 | 0.030 |
Why?
|
Austria | 1 | 2016 | 203 | 0.030 |
Why?
|
Multilevel Analysis | 1 | 2016 | 142 | 0.030 |
Why?
|
Switzerland | 1 | 2016 | 255 | 0.030 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2016 | 70 | 0.030 |
Why?
|
Cocaine-Related Disorders | 1 | 1999 | 460 | 0.030 |
Why?
|
Metabolic Clearance Rate | 1 | 2016 | 380 | 0.030 |
Why?
|
Brain Hemorrhage, Traumatic | 1 | 2015 | 18 | 0.030 |
Why?
|
Orientation | 1 | 1998 | 327 | 0.030 |
Why?
|
Osmolar Concentration | 1 | 1997 | 683 | 0.030 |
Why?
|
Inositol | 1 | 2017 | 218 | 0.030 |
Why?
|
Debridement | 1 | 1998 | 492 | 0.030 |
Why?
|
Functional Laterality | 2 | 2018 | 2290 | 0.030 |
Why?
|
Nitriles | 1 | 2001 | 956 | 0.030 |
Why?
|
Genetic Markers | 2 | 2012 | 2634 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2017 | 3760 | 0.030 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2016 | 168 | 0.030 |
Why?
|
Intracranial Hypertension | 1 | 1998 | 186 | 0.030 |
Why?
|
Polyglycolic Acid | 1 | 2017 | 407 | 0.030 |
Why?
|
Retreatment | 1 | 2017 | 610 | 0.030 |
Why?
|
Choline | 1 | 2017 | 493 | 0.030 |
Why?
|
Minority Groups | 1 | 2003 | 1223 | 0.030 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2019 | 841 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2005 | 6489 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2017 | 3508 | 0.030 |
Why?
|
Sleep Deprivation | 1 | 2022 | 832 | 0.030 |
Why?
|
Hindlimb | 1 | 2017 | 504 | 0.030 |
Why?
|
Life Style | 2 | 2018 | 3835 | 0.030 |
Why?
|
Health Services Accessibility | 2 | 2024 | 5137 | 0.030 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2000 | 1107 | 0.030 |
Why?
|
Wakefulness | 1 | 2022 | 1245 | 0.030 |
Why?
|
Anticoagulants | 1 | 2010 | 4599 | 0.030 |
Why?
|
Mental Recall | 1 | 2001 | 1205 | 0.030 |
Why?
|
Long-Term Care | 1 | 2018 | 607 | 0.030 |
Why?
|
Aspartic Acid | 1 | 2017 | 576 | 0.030 |
Why?
|
Hospital Costs | 1 | 2001 | 985 | 0.030 |
Why?
|
Bones of Lower Extremity | 1 | 2014 | 6 | 0.030 |
Why?
|
Professional Competence | 1 | 2018 | 447 | 0.030 |
Why?
|
Glutathione | 1 | 2017 | 589 | 0.030 |
Why?
|
Mental Status Schedule | 1 | 2015 | 321 | 0.030 |
Why?
|
Speech Disorders | 1 | 2015 | 189 | 0.030 |
Why?
|
Adrenal Insufficiency | 1 | 2015 | 184 | 0.030 |
Why?
|
Computer Simulation | 2 | 2018 | 6196 | 0.030 |
Why?
|
Thiazoles | 1 | 2001 | 1483 | 0.030 |
Why?
|
Equipment Failure Analysis | 1 | 2016 | 868 | 0.030 |
Why?
|
Statistics as Topic | 2 | 2015 | 2373 | 0.030 |
Why?
|
Physician's Role | 1 | 2020 | 943 | 0.030 |
Why?
|
Blotting, Western | 3 | 2005 | 5179 | 0.030 |
Why?
|
Linear Models | 2 | 2015 | 5952 | 0.030 |
Why?
|
Equipment Design | 2 | 2016 | 3582 | 0.030 |
Why?
|
Personal Satisfaction | 1 | 2017 | 643 | 0.030 |
Why?
|
Calibration | 1 | 2015 | 816 | 0.030 |
Why?
|
Infrared Rays | 1 | 2014 | 249 | 0.030 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2017 | 454 | 0.030 |
Why?
|
Affective Symptoms | 1 | 2015 | 407 | 0.030 |
Why?
|
Metabolic Diseases | 1 | 2019 | 658 | 0.030 |
Why?
|
Iatrogenic Disease | 1 | 2016 | 547 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2000 | 1372 | 0.030 |
Why?
|
Indoles | 1 | 2001 | 1839 | 0.030 |
Why?
|
Risk | 2 | 2021 | 9687 | 0.030 |
Why?
|
Finite Element Analysis | 1 | 2014 | 431 | 0.030 |
Why?
|
Body Mass Index | 2 | 2023 | 12720 | 0.030 |
Why?
|
Heat-Shock Proteins | 1 | 2016 | 822 | 0.030 |
Why?
|
Blood Pressure | 2 | 2018 | 8554 | 0.030 |
Why?
|
Television | 1 | 2014 | 409 | 0.030 |
Why?
|
APACHE | 1 | 2012 | 277 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2012 | 2916 | 0.020 |
Why?
|
Organ Specificity | 1 | 2016 | 2008 | 0.020 |
Why?
|
Epilepsy | 1 | 2007 | 3310 | 0.020 |
Why?
|
Organ Size | 1 | 2016 | 2252 | 0.020 |
Why?
|
Surgicenters | 1 | 2011 | 46 | 0.020 |
Why?
|
Disease Progression | 2 | 2019 | 13284 | 0.020 |
Why?
|
Water | 1 | 1997 | 1395 | 0.020 |
Why?
|
Hypothyroidism | 1 | 2015 | 658 | 0.020 |
Why?
|
Hearing | 1 | 2014 | 482 | 0.020 |
Why?
|
Perception | 1 | 2017 | 1198 | 0.020 |
Why?
|
Information Storage and Retrieval | 1 | 2016 | 824 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2023 | 3587 | 0.020 |
Why?
|
Health Policy | 2 | 2016 | 2661 | 0.020 |
Why?
|
Pandemics | 2 | 2020 | 8388 | 0.020 |
Why?
|
Occupations | 1 | 2012 | 517 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2003 | 3528 | 0.020 |
Why?
|
Human Growth Hormone | 1 | 2015 | 683 | 0.020 |
Why?
|
Spatial Behavior | 1 | 2010 | 90 | 0.020 |
Why?
|
Respiration | 1 | 1996 | 1653 | 0.020 |
Why?
|
Focus Groups | 1 | 2014 | 1321 | 0.020 |
Why?
|
Health Facility Administrators | 1 | 2009 | 31 | 0.020 |
Why?
|
Pregnancy | 2 | 2022 | 29144 | 0.020 |
Why?
|
Speech | 1 | 2014 | 540 | 0.020 |
Why?
|
Hypogonadism | 1 | 2015 | 799 | 0.020 |
Why?
|
Neoplasms | 1 | 2018 | 21683 | 0.020 |
Why?
|
Mice | 3 | 2022 | 81183 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2017 | 2216 | 0.020 |
Why?
|
Hand Strength | 1 | 2012 | 448 | 0.020 |
Why?
|
Data Collection | 1 | 2018 | 3341 | 0.020 |
Why?
|
Progesterone | 2 | 2004 | 776 | 0.020 |
Why?
|
Comprehension | 1 | 2014 | 610 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2019 | 1439 | 0.020 |
Why?
|
Mood Disorders | 1 | 2015 | 1106 | 0.020 |
Why?
|
Hand | 1 | 2014 | 884 | 0.020 |
Why?
|
Cause of Death | 1 | 2019 | 3584 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2014 | 2029 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2024 | 4371 | 0.020 |
Why?
|
Observation | 1 | 2010 | 312 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2001 | 5391 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2016 | 3557 | 0.020 |
Why?
|
Femur | 1 | 2014 | 1297 | 0.020 |
Why?
|
Spinal Cord | 1 | 2016 | 1809 | 0.020 |
Why?
|
Rotarod Performance Test | 1 | 2007 | 64 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2000 | 3748 | 0.020 |
Why?
|
Blood Proteins | 1 | 2012 | 1124 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2005 | 12072 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2009 | 1420 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2002 | 7913 | 0.020 |
Why?
|
Estrogens | 2 | 2004 | 1566 | 0.020 |
Why?
|
Spinal Fusion | 1 | 2015 | 1241 | 0.020 |
Why?
|
Ligands | 1 | 2013 | 3282 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2009 | 780 | 0.020 |
Why?
|
Medial Forebrain Bundle | 1 | 2005 | 45 | 0.020 |
Why?
|
Leptin | 1 | 2014 | 1599 | 0.020 |
Why?
|
Visual Perception | 1 | 2014 | 1420 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2018 | 3966 | 0.020 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 2004 | 46 | 0.020 |
Why?
|
Dextroamphetamine | 1 | 2005 | 129 | 0.020 |
Why?
|
Space Perception | 1 | 2008 | 475 | 0.020 |
Why?
|
Image Enhancement | 1 | 2016 | 2921 | 0.020 |
Why?
|
Educational Status | 1 | 2013 | 2540 | 0.020 |
Why?
|
Decision Making | 1 | 2019 | 3887 | 0.020 |
Why?
|
Research Support as Topic | 1 | 2009 | 705 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2017 | 3396 | 0.020 |
Why?
|
Calcium | 1 | 1998 | 5756 | 0.020 |
Why?
|
Boston | 1 | 2017 | 9313 | 0.020 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2005 | 375 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12354 | 0.020 |
Why?
|
F2-Isoprostanes | 1 | 2004 | 35 | 0.020 |
Why?
|
Electric Power Supplies | 1 | 2004 | 99 | 0.010 |
Why?
|
Nerve Degeneration | 1 | 2008 | 748 | 0.010 |
Why?
|
Rotation | 1 | 2005 | 523 | 0.010 |
Why?
|
Patient Participation | 1 | 2013 | 1457 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2015 | 3589 | 0.010 |
Why?
|
Receptors, Serotonin, 5-HT1 | 1 | 2002 | 13 | 0.010 |
Why?
|
Receptors, Dopamine D2 | 1 | 2005 | 475 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14557 | 0.010 |
Why?
|
Neurotoxins | 1 | 2004 | 237 | 0.010 |
Why?
|
Program Development | 1 | 2009 | 1316 | 0.010 |
Why?
|
Anthropology, Cultural | 1 | 2003 | 99 | 0.010 |
Why?
|
Electrophysiology | 1 | 2005 | 1308 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2013 | 2576 | 0.010 |
Why?
|
Physical Exertion | 1 | 2005 | 695 | 0.010 |
Why?
|
Oxygen Radioisotopes | 1 | 2001 | 76 | 0.010 |
Why?
|
Smoking | 1 | 2018 | 8987 | 0.010 |
Why?
|
Bone and Bones | 1 | 2012 | 2575 | 0.010 |
Why?
|
Electrodes, Implanted | 1 | 2005 | 824 | 0.010 |
Why?
|
Glioblastoma | 1 | 2016 | 3481 | 0.010 |
Why?
|
Wound Healing | 1 | 2012 | 2785 | 0.010 |
Why?
|
Electric Stimulation | 1 | 2005 | 1767 | 0.010 |
Why?
|
Models, Biological | 1 | 2016 | 9583 | 0.010 |
Why?
|
Pennsylvania | 1 | 2001 | 613 | 0.010 |
Why?
|
Apoptosis | 1 | 2016 | 9727 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2013 | 4665 | 0.010 |
Why?
|
Hospital Charges | 1 | 2001 | 362 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2012 | 3022 | 0.010 |
Why?
|
Vagina | 1 | 2004 | 825 | 0.010 |
Why?
|
Vitamin D | 1 | 2012 | 3223 | 0.010 |
Why?
|
Massachusetts | 1 | 2011 | 8663 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2015 | 9648 | 0.010 |
Why?
|
Kinetics | 1 | 2005 | 6473 | 0.010 |
Why?
|
Actins | 1 | 2005 | 2121 | 0.010 |
Why?
|
Time | 1 | 1998 | 542 | 0.010 |
Why?
|
Cues | 1 | 2001 | 873 | 0.010 |
Why?
|
Alcohol-Related Disorders | 1 | 1998 | 234 | 0.010 |
Why?
|
Attitude to Health | 1 | 2004 | 2052 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2016 | 8863 | 0.010 |
Why?
|
Urban Population | 1 | 2003 | 2021 | 0.010 |
Why?
|
Prefrontal Cortex | 1 | 2005 | 2147 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2004 | 2266 | 0.010 |
Why?
|
Cell Survival | 1 | 2004 | 5882 | 0.010 |
Why?
|
Infant | 1 | 2015 | 35136 | 0.010 |
Why?
|
Child, Preschool | 1 | 2015 | 41006 | 0.010 |
Why?
|
Genotype | 1 | 2007 | 12951 | 0.010 |
Why?
|
Survival Analysis | 1 | 2003 | 10252 | 0.010 |
Why?
|
Signal Transduction | 1 | 2013 | 23403 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2001 | 4042 | 0.000 |
Why?
|
Pneumonia | 1 | 1997 | 2133 | 0.000 |
Why?
|